Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

RPHM Reneo Pharmaceuticals

Watchlist
3.030
-0.190-5.90%
Close  02/08 16:00 ET
3.0300.0000.00%
Post Mkt Price 02/08 16:00 ET
High
3.200
Open
3.170
Turnover
86.53K
Low
3.030
Pre Close
3.220
Volume
27.72K
Market Cap
74.32M
P/E(TTM)
Loss
52wk High
5.765
Shares
24.53M
P/E(Static)
Loss
52wk Low
1.790
Float Cap
27.47M
Bid/Ask %
0.00%
Historical High
17.180
Shs Float
9.07M
Volume Ratio
0.55
Historical Low
1.790
Dividend TTM
--
Div Yield TTM
--
P/B
0.66
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.31%
Amplitude
5.28%
Avg Price
3.121
Lot Size
1
Float Cap
27.47M
Bid/Ask %
0.00%
Historical High
17.180
Shs Float
9.07M
Volume Ratio
0.55
Historical Low
1.790
Dividend TTM
--
P/B
0.66
Dividend LFY
--
Turnover Ratio
0.31%
Amplitude
5.28%
Avg Price
3.121
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.
CEO: Mr. Gregory J. Flesher
Market: NASDAQ
Listing Date: 04/09/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist